MarketGrader Israel Index


Five Largest Companies
Symbol Name Grade Market Cap Country
TEVA Teva Pharmaceutical Industries Limited S 57.9 ¤40,250 IL
LUMI.IL Bank Leumi Le-Israel B.M. 74.9 ¤38,039 IL
POLI.IL Bank Hapoalim BM 67.9 ¤34,479 IL
PHOE.IL Phoenix Financial Ltd 62.8 ¤17,165 IL
CHKP Check Point Software Technologies Ltd. 64.2 ¤13,416 IL

Five Smallest Companies
Symbol Name Grade Market Cap Country
KMDA.IL Kamada Ltd 53.5 ¤462 IL
MNIF.IL Menif - Financial Services Ltd. 72.7 ¤578 IL
NAWI.IL Nawi Group Ltd. 66.4 ¤640 IL
ANLT.IL Analyst I.M.S. Investment Management Ser 77.1 ¤672 IL
ODD ODDITY Tech Ltd. Class A 68.0 ¤695 IL

Companies with Most Selections Among Current Components
Symbol Name Grade Times* Country
CHKP Check Point Software Technologies Ltd. 64.2 34 IL
NICE NICE Ltd. Sponsored ADR 62.5 26 IL
POLI.IL Bank Hapoalim BM 67.9 25 IL
LUMI.IL Bank Leumi Le-Israel B.M. 74.9 23 IL
ITRN Ituran Location and Control Ltd. 78.3 15 IL
TEVA Teva Pharmaceutical Industries Limited S 57.9 15 IL
IDIN.IL I.D.I. Insurance Company Ltd. 67.7 11 IL
MMHD.IL Menora Mivtachim Holdings Ltd. 66.4 11 IL
ONE.IL One Software Technologies Ltd. 65.3 11 IL
SMT.IL Summit Real Estate Holdings Ltd 58.3 9 IL
*Number of times selected at Index semi-annual reconstitutions since inception date.
Index Bio
Average Market Cap ¤6,839
Median Market Cap ¤1,271
Avg. 3 Mo. Dollar Vol. ¤28,441,496
Avg. 3 Mo. Trading Vol. 805,403
Last Rebalance Date 03/23/2026
Companies Replaced 13
Biggest Sector Increase Health Care
Biggest Sector Decrease Technology

Fundamental Attributes
Trailing P/E Ratio (12 Mo.) 13.9
Forward P/E Ratio (12 Mo.) 14.5
Price/Book Ratio 3.8
Avg. Revenue Chg. - 3 Yr 69.5%
Avg. Op. Income Chg. - 3 Yr. 156.4%
Avg. EPS Growth - 3 Yr. 30.2%
Avg. EPS Growth - 1 Yr. 24.3%
Avg. Operating Margin 23.6%
Avg. LT Debt to Total Capital 41.2%
Avg. Return on Equity 30.2%
Dividend Yield 2.7%
Index Average Grade
Israel Index 67.87
Country Breakdown
Israel 100.0%
For more information on this index please contact us

Get Access to the World's Smartest Global Research Platform

Don't wait another day to make better informed, higher-returning investments.

TRY IT FOR FREE